$CLFD

Beranek Cheryl sold $71K of CLFD

Beranek Cheryl (Chief Executive Officer) sold 1,778 shares of Clearfield, Inc. (CLFD) at $40.06 on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Beranek Cheryl
Published Jul 6, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLFD
Neutral
medium confidence
Mentioned
$CLFD
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLFDNeutralLow
01

Why it matters

The CEO’s planned open-market sale reduces the likelihood of a strong negative fundamental signal; traders may treat it as routine unless paired with other negative disclosures.

02

Market read

A routine 10b5-1 insider sale was disclosed; it is unlikely to change the investment thesis absent additional company-specific news.

03

What to watch

The filing does not indicate whether other insiders sold/bought, nor does it provide context on total compensation, tax events, or diversification targets.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-06 after-hours; reflects sale executed 2026-07-01.

Background

The article is a primary-source SEC Form 4 insider transaction for Clearfield, Inc. (CLFD).

Company-level read

Ticker impact

$CLFDNeutralMedium confidence
Context

Clearfield CEO Beranek Cheryl sold 1,778 shares on 2026-07-01 at $40.0600/share under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

Form 4 shows a planned open-market sale (10b5-1) by the CEO; the article provides no new operational, financial, or regulatory developments.

Market effects

No clear sector read-through; the disclosure is company-specific and does not cite industry catalysts.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with perceived valuation risk or liquidity needs.

Key entities

  • Clearfield, Inc.

    Company whose CEO filed the Form 4 insider sale disclosure.

  • Beranek Cheryl

    CEO and director who sold shares under a pre-arranged 10b5-1 plan.

Related articles

$CLFDMedAI 8/10

Clearfield Q3 Earnings Call Highlights

Clearfield (NASDAQ:CLFD) reported Q3 gross margin of 31.8% versus 35.3% a year earlier, with one-time items reducing margin by about 1.8 points, and operating expenses down 6% to $11.4M. Management cited constrained broadband demand and BEAD delays, plus limited fiber supply, and lowered FY2026 guidance to $151M-$155M net sales and $0.14-$0.21 diluted EPS. CLFD repurchased ~31,000 shares for $897k.

$CLFDMedAI 8/10

Clearfield: Fiscal Q3 Earnings Snapshot

Clearfield Inc. (CLFD) reported fiscal Q3 earnings of $3 million, or 22 cents per share, on revenue of $43.9 million. For the quarter ending in September, the company expects revenue of $38 million to $42 million. For the full year, it forecasts earnings of 14 to 21 cents per share and revenue of $151 million to $155 million.